| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 29.936 | 41.538 | 59.931 | 67.556 | 66.272 | 67.612 | 72.507 | 91.004 | 100.064 |
| Total Income - EUR | - | 29.936 | 42.414 | 59.931 | 67.558 | 66.274 | 67.613 | 72.508 | 96.658 | 102.026 |
| Total Expenses - EUR | - | 28.350 | 37.995 | 48.067 | 48.946 | 52.584 | 50.794 | 41.876 | 45.745 | 50.460 |
| Gross Profit/Loss - EUR | - | 1.586 | 4.419 | 11.864 | 18.612 | 13.690 | 16.820 | 30.632 | 50.913 | 51.566 |
| Net Profit/Loss - EUR | - | 1.286 | 3.995 | 11.279 | 17.999 | 13.315 | 16.237 | 29.920 | 49.965 | 48.634 |
| Employees | - | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Ina Tofan Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 7.636 | 5.261 | 2.961 | 742 | 0 | 0 | 0 | 19.884 | 14.317 |
| Current Assets | - | 4.425 | 4.915 | 11.115 | 17.003 | 14.664 | 14.744 | 32.785 | 52.149 | 52.380 |
| Inventories | - | 0 | 0 | 0 | 211 | 0 | 0 | 0 | 481 | 0 |
| Receivables | - | 1.689 | 3.198 | 5.342 | 5.235 | 4.928 | 4.973 | 20.413 | 28.654 | 6.046 |
| Cash | - | 2.736 | 1.717 | 5.773 | 11.558 | 9.736 | 9.771 | 12.371 | 23.014 | 46.334 |
| Shareholders Funds | - | 1.330 | 5.303 | 11.322 | 42 | 6.243 | 2.127 | 29.960 | 50.006 | 48.682 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 10.913 | 4.873 | 2.753 | 17.875 | 8.424 | 12.668 | 2.835 | 20.056 | 18.015 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.971 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ina Tofan Medical Srl